Drug General Information
Drug ID
D03GYK
Former ID
DPR000067
Drug Name
Laropiprant+niacin
Synonyms
Tredaptive (TN)
Drug Type
Small molecular drug
Indication Dyslipidaemias [ICD9: 272; ICD10:E78] Discontinued in Phase 3 [522926]
Company
Merck
Structure
Download
2D MOL

3D MOL

Formula
C27H24ClFN2O6S
Canonical SMILES
CS(=O)(=O)C1=C2C(=CC(=C1)F)C3=C(N2CC4=CC=C(C=C4)Cl)C(CC<br />3)CC(=O)O.C1=CC(=CN=C1)C(=O)O
InChI
1S/C21H19ClFNO4S.C6H5NO2/c1-29(27,28)18-10-15(23)9-17-16-7-4-13(8-19(25)26)20(16)24(21(17)18)11-12-2-5-14(22)6-3-12;8-6(9)5-2-1-3-7-4-5/h2-3,5-6,9-10,13H,4,7-8,11H2,1H3,(H,25,26);1-4H,(H,8,9)/t13-;/m1./s1
InChIKey
ZZRFQBQNZLFESZ-BTQNPOSSSA-N
CAS Number
CAS 571170-77-9
PubChem Compound ID
PubChem Substance ID
SuperDrug ATC ID
C04AC01
SuperDrug CAS ID
cas=000059676
Target and Pathway
Target(s) Prostaglandin D2 receptor Target Info Antagonist [536740]
KEGG Pathway Neuroactive ligand-receptor interaction
Pathway Interaction Database Thromboxane A2 receptor signaling
PathWhiz Pathway Intracellular Signalling Through PGD2 receptor and Prostaglandin D2
Reactome Prostanoid ligand receptors
G alpha (s) signalling events
WikiPathways Prostaglandin Synthesis and Regulation
GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
GPCR ligand binding
GPCR downstream signaling
References
Ref 522926ClinicalTrials.gov (NCT01054508) Effect of Tredaptive on Serum Lipoproteins and Inflammatory Markers. U.S. National Institutes of Health.
Ref 536740Emerging antidyslipidemic drugs. Expert Opin Emerg Drugs. 2008 Jun;13(2):363-81.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.